Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Le Bert

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Cell Reports|April 14, 2015
Genome-derived cytosolic DNA mediates type I interferon-dependent rejection of B cell lymphoma cellsYu J Shen, Nina Le Bert, Anuja A Chitre, et al.
Journal of Hepatology|July 27, 2019
Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis BNina Le Bert, Loghman Salimzadeh, Upkar Singh Gill, et al.
Cancer Research|March 5, 2014
RAE1 ligands for the NKG2D receptor are regulated by STING-dependent DNA sensor pathways in lymphomaAdeline R Lam, Nina Le Bert, Samantha Sw Ho, et al.
Cell Reports. Medicine|October 18, 2022
A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccinesJoey Ming Er Lim, Shou Kit Hang, Smrithi Hariharaputran, et al.
Scientific Reports|October 13, 2023
BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort studyChee Fu Yung, Nina Le Bert, Kai Qian Kam, et al.
The Journal of Clinical Investigation|May 10, 2022
Favorable vaccine-induced SARS-CoV-2-specific T cell response profile in patients undergoing immune-modifying therapiesMartin Qui, Nina Le Bert, Webber Pak Wo Chan, et al.
Gastroenterology|March 5, 2025
The Impact of Hepatitis B Surface Antigen Reduction via Small Interfering RNA Treatment on Natural and Vaccine (BRII-179)-Induced Hepatitis B Virus-Specific Humoral and Cellular Immune ResponsesYun Ji, Nina Le Bert, Grace Lai-Hung Wong, et al.
Med (New York, N.Y.)|January 24, 2022
Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipientsNicholas Kim Huat Khoo, Joey Ming Er Lim, Upkar S Gill, et al.
The Journal of Clinical Investigation|January 9, 2018
Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuationLaura Rivino, Nina Le Bert, Upkar S Gill, et al.
Cell Reports|January 31, 2021
Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patientsAnthony T Tan, Martin Linster, Chee Wah Tan, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Cell Reports|April 14, 2015
Genome-derived cytosolic DNA mediates type I interferon-dependent rejection of B cell lymphoma cellsYu J Shen, Nina Le Bert, Anuja A Chitre, et al.
Journal of Hepatology|July 27, 2019
Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis BNina Le Bert, Loghman Salimzadeh, Upkar Singh Gill, et al.
Cancer Research|March 5, 2014
RAE1 ligands for the NKG2D receptor are regulated by STING-dependent DNA sensor pathways in lymphomaAdeline R Lam, Nina Le Bert, Samantha Sw Ho, et al.
Cell Reports. Medicine|October 18, 2022
A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccinesJoey Ming Er Lim, Shou Kit Hang, Smrithi Hariharaputran, et al.
Scientific Reports|October 13, 2023
BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort studyChee Fu Yung, Nina Le Bert, Kai Qian Kam, et al.
The Journal of Clinical Investigation|May 10, 2022
Favorable vaccine-induced SARS-CoV-2-specific T cell response profile in patients undergoing immune-modifying therapiesMartin Qui, Nina Le Bert, Webber Pak Wo Chan, et al.
Gastroenterology|March 5, 2025
The Impact of Hepatitis B Surface Antigen Reduction via Small Interfering RNA Treatment on Natural and Vaccine (BRII-179)-Induced Hepatitis B Virus-Specific Humoral and Cellular Immune ResponsesYun Ji, Nina Le Bert, Grace Lai-Hung Wong, et al.
Med (New York, N.Y.)|January 24, 2022
Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipientsNicholas Kim Huat Khoo, Joey Ming Er Lim, Upkar S Gill, et al.
The Journal of Clinical Investigation|January 9, 2018
Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuationLaura Rivino, Nina Le Bert, Upkar S Gill, et al.
Cell Reports|January 31, 2021
Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patientsAnthony T Tan, Martin Linster, Chee Wah Tan, et al.
Pageof 6